Press Release

Press Release

Biosyntrx Announces Three New Scientific Advisory Board Members

February 07, 2014


Biosyntrx, Inc., A Nutritional Biotechnology and Healthy Lifestyle Education Company is proud to announce the addition of three new scientific advisory board members:

Lucy Young, MD, is Associate Professor of Ophthalmology at the Massachusetts Eye and Ear Infirmary, Harvard Medical School. She is the director of The Lancaster Course in Ophthalmology and has been on its faculty since 1990. Her publication list includes 95 peer review papers and book chapters.  She is on the Best Doctors and U.S. News & World Report Top Doctors lists.

Richard Davis, MD, is a physician, inventor and successful serial entrepreneur who has authored nearly 400 patents and trademarks worldwide, as well as sold four start-up companies to publicaly traded companies. He is currently serving as the Chairman, President and CEO of OgenX Therapeutics, a privately-held mitochondrial medicines company focusing on solutions in Neurodegeneration, Oncology and Virology in humans and animals.  

Vincent de Luise, MD, is Assistant Clinical Professor of Ophthalmology at Yale University School of Medicine and Adjunct Clinical Assistant Professor of Ophthalmology at Weill Cornell Medical College. He serves on the editorial boards of the Cornea Journal and Eye World. As a post-doctoral fellow at Harvard University this past year, he developed a rubric for medical humanities education at both the undergraduate and medical school level.



For additional information: contact Ellen Troyer at etroyer@biosyntrx.com or at 877-327-7889.